TARDBP and Alzheimer disease: TDP-43 immunoreactivity may modify clinical features in AD and other types of dementia (Josephs et al., 2008; Lashley et al., 2011), and is also closely associated with hippocampal sclerosis (Amador-Ortiz et al., 2007; Josephs et al., 2008).